Items where Author is "Benjamin, Don"

Yes

Benjamin, Don and Hall, Michael N.. (2022) Combining metformin with lactate transport inhibitors as a treatment modality for cancer-recommendation proposal. Frontiers in Oncology, 12. p. 1034397.

Battaglioni, Stefania and Benjamin, Don and Wälchli, Matthias and Maier, Timm and Hall, Michael N.. (2022) mTOR substrate phosphorylation in growth control. Cell, 185 (11). pp. 1814-1836.

Benjamin, Don and Robay, Dimitri and Hindupur, Sravanth K. and Pohlmann, Jens and Colombi, Marco and El-Shemerly, Mahmoud Y. and Maira, Sauveur-Michel and Moroni, Christoph and Lane, Heidi A. and Hall, Michael N.. (2018) Dual Inhibition of the Lactate Transporters MCT1 and MCT4 Is Synthetic Lethal with Metformin due to NAD+ Depletion in Cancer Cells. Cell Reports, 25 (11). pp. 3047-3058.e4.

Benjamin, Don and Hall, Michael N.. (2017) mTORC1 Controls Synthesis of Its Activator GTP. Cell Reports , 19 (13). pp. 2643-2644.

Benjamin, Don and Colombi, Marco and Hindupur, Sravanth K. and Betz, Charles and Lane, Heidi A. and El-Shemerly, Mahmoud Y. M. and Lu, Min and Quagliata, Luca and Terracciano, Luigi and Moes, Suzette and Sharpe, Timothy and Wodnar-Filipowicz, Aleksandra and Moroni, Christoph and Hall, Michael N.. (2016) Syrosingopine sensitizes cancer cells to killing by metformin. Science Advances, 2 (12). e1601756.

Benjamin, Don and Colombi, Marco and Moroni, Christoph and Hall, Michael N.. (2011) Rapamycin passes the torch: a new generation of mTOR inhibitors. Nature Reviews. Drug Discovery, 10 (11). pp. 868-880.

No

Benjamin, Don and Hall, Michael N.. (2019) Lactate jump-starts mTORC1 in cancer cells. EMBO Reports, 20 (6). e48302.

Benjamin, Don and Colombi, Marco and Moroni, Christoph and Hall, Michael N.. (2019) mTOR dependent transformed human cells have a distinct set of essential genes from bcr-abl transformed cells. bioRxiv. pp. 1-24.